Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

Bayer hires chief information officer

May 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information

Johannes Schubmehl has been appointed chief information officer of Bayer HealthCare. Schubmehl succeeded Matthias Moritz, who left the company at …
Appointment
Actavis image

Actavis snaps up Warner Chilcott

May 22, 2013 Research and Development, Sales and Marketing Actavis, Warner Chilcott

Actavis is to buy Dublin-based firm Warner Chilcott in an $8.5 billion deal which will see the Warner name disappear …
News
pfizerworld

Pfizer abandons cancer trial

May 22, 2013 Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …
News
wefwefwefw

Board changes at Boehringer Ingelheim

May 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker

Boehringer’s Professor Wolfram Carius is stepping down from the Board to be replaced by Dr Wolfgang Baiker. Carius who is …
Appointment

Bayer to buy Steigerwald

May 21, 2013 Sales and Marketing Bayer, steigerwald

Bayer is to buy herbal medicines specialist Steigerwald Arzneimittelwerk in a deal which it says is motivated in part by …
News
eisai_ricardo_gonzalez_-balboa-90-2-1368715273mr

New general manager for Eisai in Mexico

May 21, 2013 Manufacturing and Production, Research and Development, Sales and Marketing

Eisai has appointed Ricardo Gonzalez Balboa to the position of general manager, Eisai Mexico. In this position, Gonzalez Balboa will …
Appointment

New fund for electronic prescribing

May 21, 2013 Sales and Marketing Francis report, IT, NHS, electronic prescribing

A new £260 million fund is to help accelerate progress toward electronic prescribing in NHS hospitals.The government says it is …
News
Abbvie image

AbbVie and Galapagos extend deal

May 21, 2013 Sales and Marketing AbbVie, Crohn's, Galapagos

AbbVie and Belgian biotech Galapagos have bolted on a development programme for Crohn’s disease to the selective JAK1 inhibitor they …
News
NHS image

Working with the NHS in austerity

May 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards

The National Health Service, perhaps the UK’s most deeply loved institution, is facing a double threat. On one hand, there …
Feature

Promise for Lundbeck and Takeda’s depression drug

May 20, 2013 Research and Development, Sales and Marketing Lexapro, Lundbeck, Takeda, cymbalta, depression, lilly

Takeda and Lundbeck’s treatment for major depressive disorder has demonstrated a significant improvement in patients’ symptoms during trials. Brintellix (Vortioxetine) …
News
kela-madar

Biotec Services expands presence in Israel

May 20, 2013 Research and Development, Sales and Marketing Biotec

Clinical supplies firm Biotec Services International has expanded its presence in Israel with the appointment of a new Israeli agent. …
Appointment
rawlins_nice

NICE chairman joins biotech Board

May 17, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Intra-Cellular Therapies, NICE, Rawlins

Biotech firm Intra-Cellular Therapies has appointed former NICE chairman Professor Sir Michael Rawlins to its Board of directors. Rawlins was …
Appointment

Government ‘joins-up’ system

May 15, 2013 Sales and Marketing NHS, NICE, government, king's fund

The government has launched its plans to create ‘a truly joined-up system’ for the provision of health and social care …
News
Elan image

Elan signs $1 billion finance deal with Theravance

May 15, 2013 Research and Development, Sales and Marketing Elan, Theravance, royalty pharma

Elan has struck a novel deal with Theravance which gives it a share of potential future royalties from its respiratory …
News
sumant_hospira__033retoucha

Hospira Reappoints chief scientific officer

May 15, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hospira

Injectable drugs and infusion tech firm Hospira has announced that Sumant Ramachandra has been reappointed to his role as senior …
Appointment
The Gateway to Local Adoption Series

Latest content

Vedana emerges with $46m funding to advance next-generation migraine therapies

June 26, 2026

Phase 1 study supports further development of inhaled respiratory therapy

June 25, 2026

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026

Axplora consolidates liver disease API manufacturing in India

June 23, 2026

Data suggests avapritinib improves quality of life for patients with mastocytosis

June 22, 2026